PF4 and systemic sclerosis: Furthermore, it has been observed that plasmacytoid dendritic cells (pDCs) from patients with systemic sclerosis produce elevated levels of proinflammatory chemokine CXCL4, which has been linked to the risk and progression of the disease (42).